It was found that the functional defects of Tregs in MS can be repaired in vitro using a simple UCMSCs priming approach as UCMSCs significantly increased the frequency of CD4+CD25+CD127low/- Tregs in resting CD4+ T cells (P < 0.01) from MS. Here, CD4 is linked to myeloid sarcoma.